SCHEMBL5408522

SCHEMBL5408522

CNc1nc(Nc2ccccc2OC)ncc1[N+](=O)[O-]

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 3/20 0.65
L3MBTL1 Q9Y468 2/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
MAPK1 P28482 3/20 0.57
ALDH1A1 P00352 1/20 0.57
GSK3B P49841 4/20 0.54
ALK Q9UM73 3/20 0.54
GSK3A P49840 3/20 0.54
PLK1 P53350 2/20 0.54
INSR P06213 2/20 0.54
IGF1R P08069 2/20 0.54
CDK5 Q00535 2/20 0.54
CDC7 O00311 1/20 0.54
PLK4 O00444 1/20 0.54
CHEK1 O14757 1/20 0.54
DCLK1 O15075 1/20 0.54
CHUK O15111 1/20 0.54
PDPK1 O15530 1/20 0.54
DAPK3 O43293 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5413325 0.84 LRRK2 (0.62) LRRK2L3MBTL1MEN1KMT2AMAPK1
SCHEMBL5418647 0.83 IGF1R (0.59) LRRK2MEN1KMT2AMAPK1ALDH1A1
SCHEMBL5413522 0.80 PTK2 (0.54) LRRK2MEN1KMT2AALDH1A1GSK3B
SCHEMBL5402268 0.80 GSK3B (0.82) LRRK2L3MBTL1MEN1KMT2AMAPK1
SCHEMBL18181774 0.80 PIN1 (0.63) LRRK2L3MBTL1MEN1KMT2AMAPK1
SCHEMBL5409656 0.79 SYK (0.59) L3MBTL1MEN1KMT2AMAPK1GSK3B
SCHEMBL7458726 0.79 LRRK2 (1.00) LRRK2ALKINSRIGF1RJAK2
SCHEMBL28220480 0.78 MAPT (0.71) LRRK2L3MBTL1MEN1KMT2AMAPK1
SCHEMBL5409564 0.78 GSK3B (0.59) L3MBTL1MEN1KMT2AMAPK1ALDH1A1
SCHEMBL16134079 0.77 PLK1 (0.48) LRRK2MEN1KMT2AMAPK1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166599-B2 Trisubstituted pyrimidines BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-01-23 US disclosed
US-20050090486-A1 Trisubstituted pyrimidines BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-04-28 US disclosed
US-20030134838-A1 Trisubstituted pyrimidines BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134838-A1 Trisubstituted pyrimidines APP, PSEN1, BACE1 LRRK2 619/4885L3MBTL1 3293/4885MEN1 3119/4885
US-20050090486-A1 Trisubstituted pyrimidines APP, BACE1, PSEN1 LRRK2 775/4885L3MBTL1 4427/4885MEN1 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.